Press Releases Filter Filter Results Year 2024 (4) 2023 (5) 2022 (23) 2021 (17) 2020 (38) 2019 (36) 2018 (23) 2017 (25) 2016 (20) 2015 (25) 2014 (26) 2013 (31) 2012 (35) January 12, 2022 Early Feasibility Study Demonstrates Successful Use of Abiomed’s preCARDIA Technology January 10, 2022 Regulators Approve Impella 5.5® with SmartAssist® in Japan and Hong Kong; US FDA Grants Impella BTR® Conditional IDE Approval for First-in-Human Early Feasibility Study November 4, 2021 Two Large Studies Demonstrate Complete Revascularization with Impella® Heart Pumps Improves Ejection Fraction and Long-Term Patient Outcomes November 3, 2021 Impella® Advances to Higher Level of Recommendation in Newest ESC Guidelines November 1, 2021 TCT 2021 to Highlight Improved Patient Outcomes with Impella’s Small, Smart and Connected Technology October 28, 2021 Abiomed Announces Q2 FY 2022 Revenue of $248 Million, Up 18% Year Over Year October 7, 2021 Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification August 18, 2021 FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump August 4, 2021 Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year July 15, 2021 Abiomed First Quarter Fiscal 2022 Earnings and Conference Call Notification June 29, 2021 FDA Grants Highest Level of Approval to the Next Generation of Impella RP to Treat Right Heart Failure June 1, 2021 Abiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve Outcomes for Heart Failure Patients April 29, 2021 Abiomed Announces Record Revenue of $241 Million, up 17% Year Over Year, With 26.0% Operating Margin April 8, 2021 Abiomed Fourth Quarter Fiscal 2021 Earnings and Conference Call Notification February 17, 2021 Abiomed to Present at Upcoming Investor Conferences … 2 3 4 5 …
